A carregar...
Novel therapeutics for recurrent cervical cancer: Moving towards personalized therapy
While screening programs and HPV vaccination have decreased the incidence of cervical cancer, still over 13,000 cases occur in the United States annually. Early stage cervical cancer has an excellent long-term prognosis, with 5-year survival for localized disease being >90%. Survival decreases ma...
Na minha lista:
| Publicado no: | Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033025/ https://ncbi.nlm.nih.gov/pubmed/31939072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01249-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|